Advertisement Roche acquires Ventana's shares in tender offer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roche acquires Ventana’s shares in tender offer

Roche has announced that its wholly-owned subsidiary, Rocket Acquisition has accepted for payment all shares validly tendered, pursuant to its tender offer for all outstanding shares of common stock of Ventana Medical Systems at $89.50 per share in cash.

As of the expiration of the tender offer, a total of approximately 25,491,221 shares of Ventana common stock were tendered and not withdrawn, representing approximately 70.5% of Ventana’s outstanding shares. After expiration of the subsequent offering period, Roche will complete the acquisition of Ventana through a merger in which all shares of Ventana not owned by Roche and its subsidiaries (other than shares as to which appraisal rights are validly exercised) will be converted into the right to receive the same cash consideration per share as was paid in the tender offer.

Franz Humer, chairman and CEO of Roche, said: “We are pleased that we have successfully completed this step in the transaction and look forward to welcoming Ventana to the Roche Group.”